/Companies

Architect Therapeutics

San Diego, US · 3 known investors

Find your way into Architect Therapeutics

Sign up to see every warm intro you have to Architect Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Architect Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Architect Therapeutics is a drug discovery company that uses C-H bond activation chemistry to synthesize novel 3D small-molecule scaffolds and screen them against difficult-to-drug targets. It develops oral therapies with an emphasis on immunology and oncology.

Founders & leadership

JYJin-Quan Yu
Jin-Quan YuFounderVenture Partner at ARCH Venture Partners
JY
Jin-Quan Yu, Ph.D.Scientific Founder
BCBen Cravatt Ph.D.
Ben Cravatt Ph.D.Scientific Founder
RH
Rich Heyman, Ph.D.Scientific Founder
AY
Angie You, Ph.D.Chief Executive Officer

Investors · 3

Founder mafia

2 people who came through Architect Therapeutics went on to found or lead other companies.

Frequently asked questions

What does Architect Therapeutics do?
Architect Therapeutics is a drug discovery company that uses C-H bond activation chemistry to synthesize novel 3D small-molecule scaffolds and screen them against difficult-to-drug targets. It develops oral therapies with an emphasis on immunology and oncology.
Who founded Architect Therapeutics?
Architect Therapeutics was founded by Jin-Quan Yu, Jin-Quan Yu, Ph.D., Ben Cravatt Ph.D., Rich Heyman, Ph.D..
Who are Architect Therapeutics's investors?
Architect Therapeutics's investors include Frazier Life Sciences, OrbiMed, Viking Global.
Where is Architect Therapeutics headquartered?
Architect Therapeutics is headquartered in San Diego, US.